In Q4'19, GSK divested its Rabipur and Encepur vaccines to Bavarian Nordic for ~1B and received EC's approval for Benlysta (belimumab, IV) as the first biologic to treat Lupus in children. In Apr 2020, the company also signed an agreement with Sanofi to develop the adjuvanted COVID-19 vaccine. Total Revenue: $46.84B Total Employees: ~71,000 Pharma Segment Revenue: $41.75B Non-Pharma Segment Revenue: $4.39B Founded Year: 1891 Headquarter: New Jersey, United States Market Cap: ~$195.17B Stock Exchange: NYSE Merck & Co. is a global healthcare company delivering innovative health care products with its prescription medicines, vaccines, biologic therapies, and animal health care products and the company operates in four major segments of Pharmaceutical, Animal Health, Healthcare Services, and Alliances segments.